Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic effect of hydroxychloroquine on novel coronavirus (COVID-19)
IRCT20151222025660N2Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Arak University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20151222025660N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151222025660N2.